159 related articles for article (PubMed ID: 23730265)
21. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a general practice based hepatitis C virus screening intervention.
Anderson EM; Mandeville RP; Hutchinson SJ; Cameron SO; Mills PR; Fox R; Ahmed S; Taylor A; Spence E; Goldberg DJ
Scott Med J; 2009 Aug; 54(3):3-7. PubMed ID: 19728405
[TBL] [Abstract][Full Text] [Related]
24. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
25. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
[TBL] [Abstract][Full Text] [Related]
26. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
[TBL] [Abstract][Full Text] [Related]
27. Estimation of injecting drug users in the City of Edinburgh, Scotland, and number infected with human immunodeficiency virus.
Davies AG; Cormack RM; Richardson AM
Int J Epidemiol; 1999 Feb; 28(1):117-21. PubMed ID: 10195675
[TBL] [Abstract][Full Text] [Related]
28. Spatial distribution and characteristics of injecting drug users (IDU) in five Northeastern states of India.
Medhi GK; Mahanta J; Adhikary R; Akoijam BS; Liegise B; Sarathy K; Thomas CJ; Sarmah B
BMC Public Health; 2011 Jan; 11():64. PubMed ID: 21281465
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X; Luo J; Bai J; Yu R
Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
[TBL] [Abstract][Full Text] [Related]
30. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
[TBL] [Abstract][Full Text] [Related]
31. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release.
Bird SM; Fischbacher CM; Graham L; Fraser A
Addiction; 2015 Oct; 110(10):1617-24. PubMed ID: 25940815
[TBL] [Abstract][Full Text] [Related]
32. Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population.
Sutton AJ; McDonald SA; Palmateer N; Taylor A; Hutchinson SJ
Epidemiol Infect; 2012 Dec; 140(12):2190-8. PubMed ID: 22459739
[TBL] [Abstract][Full Text] [Related]
33. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
Miller M; Mella I; Moi H; Eskild A
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
[TBL] [Abstract][Full Text] [Related]
34. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations.
Martin NK; Vickerman P; Miners A; Foster GR; Hutchinson SJ; Goldberg DJ; Hickman M
Hepatology; 2012 Jan; 55(1):49-57. PubMed ID: 21898506
[TBL] [Abstract][Full Text] [Related]
36. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
[TBL] [Abstract][Full Text] [Related]
37. Ageing opioid users' increased risk of methadone-specific death in the UK.
Pierce M; Millar T; Robertson JR; Bird SM
Int J Drug Policy; 2018 May; 55():121-127. PubMed ID: 29573622
[TBL] [Abstract][Full Text] [Related]
38. The impact of injecting drug use status on hepatitis C-related referral and treatment.
Stoové MA; Gifford SM; Dore GJ
Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
[TBL] [Abstract][Full Text] [Related]
39. High hepatitis C incidence in new injecting drug users: a policy failure?
Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
[TBL] [Abstract][Full Text] [Related]
40. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
